82
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Multifunctional targeting micelle nanocarriers with both imaging and therapeutic potential for bladder cancer

, , , , , , , & show all
Pages 2793-2804 | Published online: 06 Jun 2012

References

  • HeXGaoJGambhirSSChengZNear-infrared fluorescent nanoprobes for cancer molecular imaging: status and challengesTrends Mol Med20101657458320870460
  • BharaliDJMousaSAEmerging nanomedicines for early cancer detection and improved treatment: current perspective and future promisePharmacol Ther201012832433520705093
  • SeniorJHFate and behavior of liposomes in vivo: a review of controlling factorsCrit Rev Ther Drug Carrier Syst198731231933542245
  • LuoJXiaoKLiYWell-defined, size-tunable, multifunctional micelles for efficient paclitaxel delivery for cancer treatmentBioconjug Chem2010211216122420536174
  • XiaoKLuoJFowlerWLA self-assembling nanoparticle for paclitaxel delivery in ovarian cancerBiomaterials2009306006601619660809
  • ZhangHAinaOHLamKSIdentification of a bladder cancer-specific ligand using a combinatorial chemistry approachUrol Oncol9292012 [Epub ahead of print.]
  • LinTYZhangHWangSTargeting canine bladder transitional cell carcinoma with a human bladder cancer-specific ligandMol Cancer201110921272294
  • TornoeCWChristensenCMeldalMPeptidotriazoles on solid phase: [1,2,3]-triazoles by regiospecific copper(i)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azidesJ Org Chem2002673057306411975567
  • DhawanDRamos-VaraJAStewartJCZhengRKnappDWCanine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancerUrol Oncol20092728429218562222
  • SchillerJHHarringtonDBelaniCPComparison of four chemotherapy regimens for advanced non-small-cell lung cancerN Engl J Med2002346929811784875
  • LeamonCPReddyJAFolate-targeted chemotherapyAdv Drug Deliv Rev2004561127114115094211
  • KwekkeboomDKrenningEPde JongMPeptide receptor imaging and therapyJ Nucl Med2000411704171311038002
  • XiaoKLiYLuoJThe effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticlesBiomaterials2011323435344621295849
  • MatsumuraYMaedaHA new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancsCancer Res198646638763922946403
  • ModiSPrakash JainJDombAJKumarNExploiting EPR in polymer drug conjugate delivery for tumor targetingCurr Pharm Des2006124785479617168778
  • KimKKimJHParkHTumor-homing multifunctional nanoparticles for cancer theragnosis: Simultaneous diagnosis, drug delivery, and therapeutic monitoringJ Control Release201014621922720403397
  • GarangerEBoturynDDumyPTumor targeting with RGD peptide ligands-design of new molecular conjugates for imaging and therapy of cancersAnticancer Agents Med Chem2007755255817896915
  • XuLPirolloKFTangWHRaitAChangEHTransferrin-liposome-mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenograftsHum Gene Ther1999102941295210609655
  • DanielsTRDelgadoTRodriguezJAHelgueraGPenichetMLThe transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancerClin Immunol200612114415816904380
  • XuLTangWHHuangCCSystemic p53 gene therapy of cancer with immunolipoplexes targeted by anti-transferrin receptor scFvMol Med2001772373411713371
  • WuAMYazakiPJTsaiSHigh-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragmentProc Natl Acad Sci U S A2000978495850010880576
  • YangLPengXHWangYAReceptor-targeted nanoparticles for in vivo imaging of breast cancerClin Cancer Res2009154722473219584158
  • HussainSPluckthunAAllenTMZangemeister-WittkeUAntitumor activity of an epithelial cell adhesion molecule targeted nanovesicular drug delivery systemMol Cancer Ther200763019302718025286
  • KirpotinDBDrummondDCShaoYAntibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal modelsCancer Res2006666732674016818648
  • PunSHTackFBellocqNCTargeted delivery of RNA-cleaving DNA enzyme (DNAzyme) to tumor tissue by transferrin-modified, cyclodextrin-based particlesCancer Biol Ther2004364165015136766
  • VinallRLZripollAWangSPanCXDevere WhiteRWMiR-34a chemo-sensitizes bladder cancer cells to cisplatin treatment regardless of P53-Rb pathway statusInt J Cancer6232011 [Epub ahead of print.]
  • TanakaMGeeJRDe La CerdaJNoninvasive detection of bladder cancer in an orthotopic murine model with green fluorescence protein cytologyJ Urol200317097597812913753
  • WatanabeTShinoharaNSazawaAAn improved intravesical model using human bladder cancer cell lines to optimize gene and other therapiesCancer Gene Ther200071575158011228536
  • NorrisAMLaingEJValliVECanine bladder and urethral tumors: a retrospective study of 115 cases 1980–1985J Vet Intern Med199261451531619591
  • MutsaersAJWidmerWRKnappDWCanine transitional cell carcinomaJ Vet Intern Med20031713614412683611
  • DeborahWKNitaWGDennisBDPattyLBTsangLLLawrenceTGNaturally-occurring canine transitional cell carcinoma of the urinary bladder A relevant model of human invasive bladder cancerUrol Oncol20005475921227289